Frontiers in the management of adult congenital heart disease

This talk provides an overview on the survival of patients with adult congenital heart disease (ACHD). The focus is to understand how to harness drugs and technology to lead positive outcomes and opportunities for patients.  

Professor Michael Gatzoulis presents the major success story in what has been offered to patients with ACHD for longevity and quality of life and furthering how we can do even better for the future.

• Understand communications with patients and personalised ACHD care. 
• Establish how we can do better with the ever-growing clinical need of ACHD.  
• Demonstrate drug and device use for life of patients.  
• Overview of transplantation and success. 

Professor Michael Gatzoulis specialises in hypertension, adult congenital heart disease and heart valve disease. 

He is the academic head of the National Centre of Pulmonary Hypertension and Adult Congenital Heart Centre at Royal Brompton Hospital.  

Additionally, he is a professor of cardiology and congenital heart disease at the National Heart and Lung Institute, Imperial College London.  

Learn more about Professor Michael Gatzoulis, his research and clinical experience here.